
501 - 1000 employees
Founded 2001
🏥 Healthcare
💼 Consulting
🧬 Biotechnology
Healthcare • Consulting • Biotechnology
Asklepios BioPharmaceutical, Inc. (AskBio) is a leading gene therapy company focused on developing treatments for debilitating genetic diseases. Wholly owned by Bayer AG, AskBio specializes in adeno-associated virus (AAV)-based gene therapies aimed at treating various neuromuscular, central nervous system, cardiovascular, and metabolic diseases. One of their notable developments is AB-1003 (LION-101), which has received FDA rare pediatric disease and orphan-drug designations for treating limb-girdle muscular dystrophy type 2I/R9. AskBio is dedicated to advancing genetic medicine, with a robust portfolio of clinical programs designed to bring innovative therapeutic options to patients worldwide.
Selected: 🆕 Date Added.
🕒 August 7
Regulatory Affairs Director guiding global submissions and health-authority strategy for AskBio’s clinical-stage gene therapy medicines. Leading cross-functional regulatory activities for advanced therapeutics.
🕒 July 17
Senior Director, Medical Affairs at AskBio focusing on global medical strategies for neuromuscular programs. Driving collaboration with cross-functional teams to ensure high-quality patient outcomes.
🕒 May 8
VP of GDNF Clinical Development leading clinical development strategy for gene therapy programs. Managing team and fostering cross-functional collaboration for regulatory approvals and launches.
🕒 February 26
Medical Director leading clinical development strategy in gene therapy for movement disorders. Overseeing clinical trials and collaborating with cross-functional teams in a biotech environment.